Detection Technology and Prospects of Clinical Application of Circulating Tumor Cells in Pancreatic Cancer

por YANG Xiaoying, QIN Cheng, ZHAO Bangbo, LI Tianhao, CAO Hongtao, WANG Weibin
Publicado 2021

Multiplexed Profiling of Extracellular Vesicles for Biomarker Development

por Cheng Jiang, Ying Fu, Guozhen Liu, Bowen Shu, Jason Davis, George K. Tofaris
Publicado 2021

The Significance of Exosomes in Pathogenesis, Diagnosis, and Treatment of Esophageal Cancer

por Jing Z, Chen K, Gong L
Publicado 2021

Liquid biopsy. A challenge for clinical laboratories

por Jiménez Wladimiro
Publicado 2020

Development of custom Surface Plasmon Resonance Au biosensor for liver cancer biomarker detection

por Sarassunta Ucci, Paola Cicatiello, Sara Spaziani, Andrea Cusano
Publicado 2021

DNA methylation in lung cancer patients: Opening a 'window of life' under precision medicine

por Runzhang Liang, Xiaosong Li, Weiquan Li, Xiao Zhu, Chen Li
Publicado 2021

Urinary Exosomal CA9 mRNA as a Novel Liquid Biopsy for Molecular Diagnosis of Bladder Cancer

por Wen J, Yang T, Mallouk N, Zhang Y, Li H, Lambert C, Li G
Publicado 2021

Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives

por Gribko A, Künzel J, Wünsch D, Lu Q, Nagel SM, Knauer SK, Stauber RH, Ding GB
Publicado 2019

Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer

por Erika Bandini, Tania Rossi, Emanuela Scarpi, Giulia Gallerani, Ivan Vannini, Samanta Salvi, Irene Azzali, Mattia Melloni, Sara Salucci, Michela Battistelli, Patrizia Serra, Roberta Maltoni, William C. Cho, Francesco Fabbri
Publicado 2021

Research Progress on CircRNA in Liquid Biopsy of Gastric Cancer

por ZHU Hao, JIA Jianchao, YU Lan
Publicado 2021

Breast-cancer detection using blood-based infrared molecular fingerprints

por Kosmas V. Kepesidis, Masa Bozic-Iven, Marinus Huber, Nashwa Abdel-Aziz, Sharif Kullab, Ahmed Abdelwarith, Abdulrahman Al Diab, Mohammed Al Ghamdi, Muath Abu Hilal, Mohun R. K. Bahadoor, Abhishake Sharma, Farida Dabouz, Maria Arafah, Abdallah M. Azzeer, Ferenc Krausz, Khalid Alsaleh, Mihaela Zigman, Jean-Marc Nabholtz
Publicado 2021

Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact

por Natasha Honoré, Rachel Galot, Cédric van Marcke, Nisha Limaye, Jean-Pascal Machiels
Publicado 2021

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

por Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K
Publicado 2018

Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer

por Marinus Huber, Kosmas V Kepesidis, Liudmila Voronina, Frank Fleischmann, Ernst Fill, Jacqueline Hermann, Ina Koch, Katrin Milger-Kneidinger, Thomas Kolben, Gerald B Schulz, Friedrich Jokisch, Jürgen Behr, Nadia Harbeck, Maximilian Reiser, Christian Stief, Ferenc Krausz, Mihaela Zigman
Publicado 2021

Liquid Biopsy in Prostate Cancer Diagnosis and Prognosis: A Narrative Review

por Seyed Saeed Tamehri Zadeh, Diana Taheri, Sepideh Shivarani, Fatemeh Khatami, Reza Kazemi
Publicado 2020

Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder

por Dong Hyeon Lee, Hana Yoon, Sanghui Park, Jeong Seon Kim, Young-Ho Ahn, Kihwan Kwon, Donghwan Lee, Kwang Hyun Kim
Publicado 2018

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer

por Maha Elazezy, Katharina Prieske, Lan Kluwe, Leticia Oliveira‐Ferrer, Sven Peine, Volkmar Müller, Linn Woelber, Barbara Schmalfeldt, Klaus Pantel, Simon A. Joosse
Publicado 2021

Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas

por Pei-Hung Chang, Hung-Ming Wang, Yung-Chia Kuo, Li-Yu Lee, Chia-Jung Liao, Hsuan-Chih Kuo, Cheng-Lung Hsu, Chun-Ta Liao, Sanger Hung-Chi Lin, Pei-Wei Huang, Tyler Min-Hsien Wu, Jason Chia-Hsun Hsieh
Publicado 2021

Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors

por Lionel Larribère, Uwe M. Martens
Publicado 2021

Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series

por Hongyan Ji, Xiaolu Long, Jia Gu, Jin Jin, Xia Mao, Zhiqiong Wang, Heng Ma, Liting Chen
Publicado 2021